C1 inhibitor level on neonatal sepsis and its relations with clinical findings
Authors:
- 17 March 2010
- journal article
- Published by Wiley in Journal of Paediatrics and Child Health
- Vol. 46 (3) , 121-124
Abstract
Background: Generalised oedema is a frequent finding during neonatal sepsis, but its aetiology remains uncertain.Objective: The objective of this study was to measure functional C1 inhibitor (fC1 inh) levels in newborns with culture‐proven sepsis, compare the results with age‐ and gestational age (GA)‐matched controls and correlate the results with the clinical course of the patients during infection, with regard to vascular leak and oedema formation.Methods: Newborns with blood culture‐proven sepsis were included and samples for C1 inh levels were obtained before the beginning of antibiotic therapy and on the 3rd day of treatment. Body weight, urine output and other treatment modalities including volume boluses were recorded. Oedema formation as a sign of vascular leak was determined by calculating percent weight change over time. Age‐ and GA‐matched newborns without infection were used as controls.Results: No difference was observed between the patient and the control groups concerning fC1 inh levels. Percent weight change in the patient group was not correlated with the C1 inh levels.Conclusion: Despite studies suggesting the role of C1 inhibitor deficiency in vascular leak during sepsis in adults, there is no information in the literature regarding the C1 inh levels of healthy or septic newborns to date. In this study, fC1 inh levels were no different than controls, necessitating the consideration of other factors causing vascular leak and oedema during neonatal sepsis.Keywords
This publication has 14 references indexed in Scilit:
- C1 inhibitor prevents Gram-negative bacterial lipopolysaccharide-induced vascular permeabilityBlood, 2005
- International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics*Pediatric Critical Care Medicine, 2005
- The Biological Role of the C1 Inhibitor in Regulation of Vascular Permeability and Modulation of Inflammation2004
- C1-inhibitor substitution therapy in septic shock and in the vascular leak syndrome induced by high doses of interleukin-2Intensive Care Medicine, 1993
- C1-esterase inhibitor substitution in sepsisThe Lancet, 1992
- Proteolytic inactivation of plasma C1- inhibitor in sepsis.Journal of Clinical Investigation, 1989
- Elevated plasma levels of the anaphylatoxins C3a and C4a are associated with a fatal outcome in sepsisThe American Journal of Medicine, 1989
- Kinetics of reaction of human C-inhibitor with the human complement system proteases Cr and CsBiochimica et Biophysica Acta (BBA) - Enzymology, 1980
- A biochemical abnormality in hereditary angioneurotic edemaThe American Journal of Medicine, 1963
- Observations on a Pro-esterase Associated with Partially Purified First Component of Human Complement (C'1).Experimental Biology and Medicine, 1956